![Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model - Kicenuik - 2017 - Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model - Kicenuik - 2017 -](https://onlinelibrary.wiley.com/cms/asset/e6de5efb-3dda-4926-a5e7-dfb25871ab6e/vco12148-fig-0001-m.jpg)
Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model - Kicenuik - 2017 -
![The Evolution of the CSTD : February 2015 : Oncology Safety - Pharmacy Purchasing & Products Magazine The Evolution of the CSTD : February 2015 : Oncology Safety - Pharmacy Purchasing & Products Magazine](https://www.pppmag.com/documents/V12N2/oncology/images/ppp_1502_oncology_figure1_2.jpg)
The Evolution of the CSTD : February 2015 : Oncology Safety - Pharmacy Purchasing & Products Magazine
![Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol | Semantic Scholar Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/97af30e68c7fb9603cb78dc052df04b96d933d4c/2-Table1-1.png)
Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol | Semantic Scholar
![PDF] Closed-System Transfer Devices For Safe Handling of Injectable Hazardous Drugs | Semantic Scholar PDF] Closed-System Transfer Devices For Safe Handling of Injectable Hazardous Drugs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a737482136eb194098c57336c0234948b7dd9f3/11-Table2-1.png)